EGFR and non-small cell lung carcinoma: These results may partly explain the recent finding that inhibition of EGFR down‐regulates PD‐L1 expression in EGFR‐mutant NSCLC.27, 28 EGFR may be involved in regulating PD‐L1 through the activation or inhibition of YAP.